BRIEF published on 11/26/2024 at 00:25, 1 year 11 months ago NexgenRx Reports Q3 Growth and Announces Dividend Financial Results Revenue Increase Dividend Declaration SaaS Solutions EBITDA Growth
BRIEF published on 11/26/2024 at 00:25, 1 year 11 months ago NexgenRx annonce une croissance au troisième trimestre et un dividende Résultats Financiers Solutions SaaS Augmentation Des Revenus Croissance De L'EBITDA Déclaration De Dividendes
PRESS RELEASE published on 11/26/2024 at 00:20, 1 year 11 months ago NexgenRx Announces Third Quarter Results and Declaration of Divdend NexgenRx announces Q3 2024 financial results, with quarterly revenue up to $4,158,667 and increased positive EBITDA of $446,448. A dividend of $0.005 per share declared for shareholders Financial Results Revenue Dividend Q3 2024 NexgenRx
BRIEF published on 10/07/2024 at 23:35, 2 years ago NexgenRx Re-Appoints Charles Burns to Board of Directors Technology Solutions Board Appointment Canada NexgenRx Charles Burns
BRIEF published on 10/07/2024 at 23:35, 2 years ago NexgenRx reconduit Charles Burns au sein de son conseil d'administration Canada Nomination Au Conseil D'administration Solutions Technologiques NexgenRx Charles Burns
PRESS RELEASE published on 10/07/2024 at 23:30, 2 years ago NexgenRx Announces Director Re-Appointment NexgenRx Inc. announces re-appointment of Charles Burns to its Board of Directors. Company provides full-service Third-Party Administrator & Technology Solutions in Canada Board Of Directors Technology Solutions Third-party Administrator NexgenRx Inc. Charles Burns
BRIEF published on 10/01/2024 at 14:05, 2 years ago NexgenRx Appoints Linda Brennan to Board of Directors Board Of Directors Corporate Governance Appointment NexgenRx Linda Brennan
BRIEF published on 10/01/2024 at 14:05, 2 years ago NexgenRx nomme Linda Brennan au conseil d'administration Conseil D'administration Gouvernance D'Entreprise Rendez-vous NexgenRx Linda Brennan
PRESS RELEASE published on 10/01/2024 at 14:00, 2 years ago NexgenRx Announces New Director NexgenRx announces the appointment of Linda Brennan as a new member to its Board of Directors. Linda brings expertise in finance and corporate governance to the company Board Of Directors Appointment Finance NexgenRx Linda Brennan
BRIEF published on 07/18/2024 at 20:05, 2 years 3 months ago NexgenRx Announces Share Issuances Under Consulting Agreement Consulting Agreement Share Issuance NexgenRx PBM Management Services SaaS Model
Published on 10/27/2026 at 21:30, 1 hour 47 minutes ago Apex Announces Closing of Over-Allotment Option
Published on 10/27/2026 at 21:15, 2 hours 2 minutes ago Goldcliff Closes First Tranche of Private PLacement
Published on 10/27/2026 at 21:10, 2 hours 7 minutes ago International Battery Metals Announces Leadership Transition
Published on 10/27/2026 at 17:47, 5 hours 30 minutes ago RecycLiCo and Alaska Energy Metals Collaborate to Test Proprietary Processing Methods on the Polymetallic Eureka Deposit, Nikolai Nickel Project, Alaska
Published on 10/27/2026 at 15:00, 8 hours 17 minutes ago PPX Intercepts High-Grade Gold, Silver, and Copper at Callanquitas, with 13.28 g/t Au, 5,204 g/t Ag and 5.4% Cu Over 1.0 m; and Completes the First Drill Hole at Portachuelos
Published on 10/27/2026 at 22:40, 36 minutes ago EQS-Adhoc: NEXTDC Limited: Financial Covenants - Compliance and Headroom
Published on 10/27/2026 at 22:30, 46 minutes ago Tensor and Münchner Taxi Zentrum Sign LOI to Put Taxi Operators at the Center of Autonomous Mobility in Germany
Published on 10/27/2026 at 20:35, 2 hours 41 minutes ago Piramal Pharma Limited Announces Results for Q2 and H1 FY27
Published on 10/27/2026 at 19:17, 3 hours 59 minutes ago ZF Finance GmbH : Indicative Maximum Acceptance Amount in relation to the Tender Offer.
Published on 10/27/2026 at 18:00, 5 hours 17 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 22, 2026
Published on 10/27/2026 at 18:00, 5 hours 17 minutes ago Nombre total de droits de vote et actions composant le capital social au 22 octobre 2026
